FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Koka Motoyama

Research Profile

Disorders

Devices

Glucose Clamp Technique

Concepts & Ideas

Chemicals & Drugs

Anatomy

Physiology

Homeostasis

Activities & Behaviors

Exercise

Co-author Network

Publications

TOP 3
Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Masayo Monden; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yoshiko Otsuka; Atsushi Shioi; Takuhito Shoji; Hiroshi Yamamoto; Tetsuya Yamamoto; Yasuhiko Yamamoto; Masanori Emoto; Shinya Fukumoto; Hidenori Koyama; Masafumi Kurajoh; Yohei Mima; Masaaki Inaba
Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2.
Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Koka Motoyama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Journal of atherosclerosis and thrombosis 2013;20(2):186-94.
2013: Masayo Monden; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yoshiko Otsuka; Atsushi Shioi; Takuhito Shoji; Hiroshi Yamamoto; Tetsuya Yamamoto; Yasuhiko Yamamoto; Masanori Emoto; Shinya Fukumoto; Hidenori Koyama; Masafumi Kurajoh; Yohei Mima; Masaaki Inaba
Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2.
Diabetes 2013;62(2):478-89.
2012: Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Diabetes research and clinical practice 2012;97(1):91-8.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Naoya Kawano; Hidenori Koyama; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yasuhisa Okuno; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Masaaki Inaba
Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2012;19(3):276-84.
2011: Yuki Nagata; Hiroshi Naka; Masanori Emoto; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Takami Miki; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Masaaki Inaba
Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Endocrine 2011;40(2):315-7.
2010: Yohei Mima; Shinya Fukumoto; Hiroki Ueno; Hidenori Koyama; Shinji Tanaka; Tomoaki Morioka; Koka Motoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease.
Osaka city medical journal 2010;56(2):27-36.
2009: Koka Motoyama; Hidenori Koyama; Masamitsu Moriwaki; Kazuhiro Emura; Shuji Okuyama; Eisuke Sato; Masayasu Inoue; Atsushi Shioi; Yoshiki Nishizawa
Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice.
Nutrition (Burbank, Los Angeles County, Calif.) 2009;25(4):421-7.
2009: Takahiro Araki; Masanori Emoto; Toshiaki Konishi; Yoshiko Ikuno; Eiko Lee; Megumi Teramura; Koka Motoyama; Hisayo Yokoyama; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.
Metabolism: clinical and experimental 2009;58(2):143-8.
2007: Megumi Teramura; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Koka Motoyama; Kayo Shinohara; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults.
Journal of atherosclerosis and thrombosis 2007;14(4):172-8.
2007: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Megumi Teramura; Eiko Lee; Koka Motoyama; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of serum fetuin-A with carotid arterial stiffness.
Clinical endocrinology 2007;66(2):246-50.
2006: Koka Motoyama; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Hitoshi Shimano; Koji Maemura; Yoshiki Nishizawa
SREBP inhibits VEGF expression in human smooth muscle cells.
Biochemical and biophysical research communications 2006;342(1):354-60.
2005: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Koka Motoyama; Tomoaki Morioka; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Osaka city medical journal 2005;51(1):19-25.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Short-term aerobic exercise improves arterial stiffness in type 2 diabetes.
Diabetes research and clinical practice 2004;65(2):85-93.
2004: Hisayo Yokoyama; Masanori Emoto; Takahiro Araki; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes.
Diabetes care 2004;27(7):1756-8.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
The Journal of clinical endocrinology and metabolism 2004;89(3):1481-4.
2003: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
Diabetes care 2003;26(8):2426-32.
2003: Koka Motoyama; Masanori Emoto; Hideki Tahara; Miyoko Komatsu; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patients.
Metabolism: clinical and experimental 2003;52(7):895-9.
2003: Shigehiko Fujiwara; Masanori Emoto; Miyoko Komatsu; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2003;10(4):246-52.